US › Healthcare

Rapid Micro Biosystems Inc (RPID)

US · Healthcare · Medical Devices

$2.06-2.83%
Last close · 2026-08-04

Latest quarter · ended 2026-03-31

Revenue
$8.0M
Revenue YoY
+11.1%
Net profit
$-14.3M
Profit YoY
-26.7%
EPS
$-0.31
EPS estimate
$-0.21
Net margin
-178.4%

EPS came in at -0.31 against a street estimate of -0.21 — a miss of 47.6%.

Key statistics

Market cap
$106.1M
Forward P/E
0.0
P/B
5.15
Book value
$0.45
EPS (TTM)
$-1.10
52-week high
$4.94
52-week low
$1.66
50-day MA
$1.91
200-day MA
$2.94
Beta
1.48

Analyst view

Analysts rate Rapid Micro Biosystems Inc a strong buy (3 buy, 0 hold, 0 sell out of 3) with an average price target of $6.67.

Shareholding

Insiders
10.27%
Institutions
43.15%

Largest institutional holders

FundStake
Bain Capital Life Sciences Investors, LLC16.93%
ABG-WTT Global Life Science Capital Partners GP Ltd3.71%
Vanguard Capital Management, LLC1.97%
Essex Investment Management Company, LLC1.77%
Advent International LP1.11%
Evernest Financial Advisors LLC0.87%
SEI Investments Co0.57%
Millennium Management LLC0.57%

See the full picture

Technicals, trade setups with a published hit rate, $AI analysis and earnings-call summaries for Rapid Micro Biosystems Inc — free to start.

Google PlayApp Store

Other Healthcare companies

Eli Lilly and CompanyJohnson & JohnsonAbbVie IncUnitedHealth Group IncorporatedMerck & Company IncNovartis AG ADRAstraZeneca PLCThermo Fisher Scientific IncNovo Nordisk A/SAmgen IncAbbott LaboratoriesGilead Sciences Inc

Data updated 2026-08-05.